GBLD-345
![]() | |
| Identifiers | |
|---|---|
| |
| PubChem (CID) | 4602899 |
| ChemSpider | 3794457 |
| ChEMBL | CHEMBL1339029 |
| Chemical and physical data | |
| Formula | C21H21N5O2 |
| Molar mass | 375.423 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
GBLD-345 is an anxiolytic drug used in scientific research, which acts as a non-selective, full-efficacy positive allosteric modulator of the GABAA receptor. It has similar effects to benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.[1]
References
- ↑ Davies LP, Barlin GB, Ireland SJ, Ngu MM (October 1992). "Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptors". Biochemical Pharmacology. 44 (8): 1555–61. doi:10.1016/0006-2952(92)90472-U. PMID 1358075.
This article is issued from Wikipedia - version of the 5/31/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
